VZV: Pathogenesis and the disease consequences of primary infection

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 675-688

  Moffat, Jennifer ^a   Ku, Chia Chi ^b   Zerboni, Leigh ^b   Sommer, Marvin ^b   Arvin, Ann ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929280306     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.038     Document Type: Chapter

References (63)

1. Annunziato, P. W., Lungu, O., Panagiotidis, C. et al. (2000). Varicella-zoster virus proteins in skin lesions: Implications for a novel role of ORF29p in chickenpox. J. Virol., 74(4), 2005-2010.
2. Arvin, A. M. (2001a). Varicella-zoster virus. 4th edn. In Fields Virol-ogy, D. M. Knipe, and P. M. Howley, eds., Vol. 2, pp. 2731-2768. Philadelphia: Lippincott-Raven.
3. Arvin, A. M. (2001b). Varicella-zoster virus: Molecular virology and virus-host interactions. Curr. Opin. Microbiol., 4(4), 442-449.
4. Asano, Y., Itakura, N., Kajita, Y. et al. (1990). Severity of viremia and clinical ndings in children with varicella. J. Infect. Dis., 161(6), 1095-1098.
5. Baiker, A., Bagowski, C., Ito, H. et al. (2004). The immediate-early 63 protein of Varicella-Zoster virus: Analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J. Virol., 78(3), 1181-1194.
6. Berarducci, B., Ikoma, M., Stamatis, S., Sommer, M., Grose, C. and Arvin, A. M. (2006). Essential functions of the unique N-terminal region of the Varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection, J. Virol, in press.
7. Besser, J., Ikoma, M., Fabel, K. et al. (2004). Differential require-ment for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells. J. Virol., 78(23), 13293-13305.
8. Besser, J., Sommer, M. H., Zerboni, L. et al. (2003). Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 pro-tein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J. Virol., 77(10), 5964-5974.
9. Che, X., Zerboni, L., Sommer, M. H., and Arvin, A. M. (2006). Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T-cells in vivo. J. Virol., 7, 3238-3248.
10. Cohen, J. I. and Nguyen, H. (1997). Varicella-zoster virus glycopro-tein I is essential for growth of virus in Vero cells. J. Virol., 71(9), 6913-6920.
11. Cohen, J. I. and Seidel, K. E. (1993). Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl Acad. Sci. USA, 90, 7376-7380.
12. Cohen, J. I. and Straus, S. E. (2001). Varicella-zoster virus and its replication. 4th edn. In Fields Virology, D. M. Knipe, and P. M. Howley, eds., Vol. 2, pp. 2707-2730. Philadelphia: Lippincott-Raven.
13. Cohen, J. I., Cox, E., Pesnicak, L., Srinivas, S., and Krogmann, T. (2004). The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J. Virol., 78(21), 11833-11840.
14. Cole, N. L. and Grose, C. (2003). Membrane fusion mediated by her-pesvirus glycoproteins: The paradigm of varicella-zoster virus. Rev. Med. Virol., 13(4), 207-222.
15. Davison, A. J. and Scott, J. E. (1986). The complete DNA sequence of varicella-zoster virus. J. Gen. Virol., 67, 1759-1816.
16. Dunkle, L. M., Arvin, A. M., Whitley, R. J. et al. (1991). A controlled trial of acyclovir for chickenpox in normal children. N. Engl. J. Med., 325(22), 1539-1544.
17. Dworsky, M., Whitley, R., and Alford, C. (1980). Herpes zoster in early infancy. Am. J. Dis. Child., 134(6), 618-619.
18. Enders, G., Miller, E., Cradock-Watson, J., Bolley, I., and Ridehalgh, M. (1994). Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases. Lancet, 343(8912), 1548-1551.
19. Feldhoff, C. M., Balfour, H. H., Jr., Simmons, R. L., Najarian, J. S., and Mauer, S. M. (1981). Varicella in children with renal transplants. J. Pediatr., 98(1), 25-31.
20. Feldman, S. and Lott, L. (1987). Varicella in children with cancer: Impact of antiviral therapy and prophylaxis. Pediatrics, 80(4), 465-472.
21. Gershon, A. A., Steinberg, S., and Silber, R. (1978). Varicella-zoster viremia. J. Pediatr., 92(6), 1033-1034.
22. Gershon, A., Steinberg, S., Greenberg, S., and Taber, L. (1980). Varicella-zoster-associated encephalitis: Detection of specic antibody in cerebrospinal uid. J. Clin. Microbiol., 12(6), 764-767.
23. Grose, C. (1981). Variation on a theme by Fenner: The pathogenesis of chicken pox. Pediatrics, 68, 735-737.
24. He, H., Boucaud, D., Hay, J., and Ruyechan, W. T. (2001). Cis and trans elements regulating expression of the varicella zoster virus gI gene. Arch. Virol. Suppl.(17), 57-70.
25. Heineman, T. C., Seidel, K., and Cohen, J. I. (1996). The varicella-zoster virus ORF66 protein induces kinase activity and is dis-pensable for viral replication. J. Virol., 70(10), 7312-7317.
26. Ito, H., Sommer, M. H., Zerboni, L. et al. (2003). Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo. J. Virol., 77(1), 489-498.
27. Jackson, M. A., Burry, V. F., and Olson, L. C. (1992). Complications of varicella requiring hospitalization in previously healthy chil-dren. Pediatr. Infect. Dis. J., 11(6), 441-445.
28. Johnson, R. and Milbourn, P. E.(1970). Centralnervoussystemman-ifestations of chickenpox. Can. Med. Assoc. J., 102(8), 831-834. Jones, J. O. and Arvin, A. M. (2006). Inhibition of the NF-KB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J. Virol., 80(11), 5113-5124.
29. Jura, E., Chadwick, E. G., Josephs, S. H. et al. (1989). Varicella-zoster virus infections in children infected with human immunode-ciency virus. Pediatr. Infect. Dis. J., 8(9), 586-590.
30. Kelley, R., Mancao, M., Lee, F., Sawyer, M., Nahmias, A., and Nesheim, S. (1994). Varicella in children with perinatally acquired human immunodeciency virus infection. J. Pedi-atr., 124(2), 271-273.
31. Kemble, G. W., Annunziato, P., Lungu, O. et al. (2000). Open read-ing frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J. Virol., 74(23), 11311-11321.
32. Kinchington, P. R., Hougland, J. K., Arvin, A. M., Ruyechan, W. T., and Hay, J. (1992). The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol., 66(1), 359-366.
33. Kinchington, P. R., Vergnes, J. P., Defechereux, P., Piette, J., and Turse, S.E. (1994). Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J. Virol., 68(6), 3570-3581.
34. Koropchak, C. M., Diaz, P. S., and Arvin, A. M. (1989). Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J. Virol., 63, 2392-2395.
35. Koropchak, C. M., Graham, G., Palmer, J. et al. (1991). Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J. Infect. Dis., 163, 1016-1022.
36. Krugman, S., Goodrich, C. H., and Ward, R. (1957). Primary varicella pneumonia. N. Engl. J. Med., 257(18), 843-848.
37. Ku, C. C., Padilla, J. A., Grose, C., Butcher, E. C., and Arvin, A. M. (2002). Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J. Virol., 76(22), 11425-11433.
38. Ku, C. C., Zerboni, L., Ito, H., Graham, B. S., Wallace, M., and Arvin, A.M. (2004). Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J. Exp. Med., 200(7), 917-925.
39. Leisenfelder, S. A. and Moffat, J. F. (2006). Varicella-zoster virus infection of human foreskin broblast cells results in atypi-cal cyclin expression and cyclin-dependent kinase activity. J. Virol. 80(11), 5577-5587.
40. Liesegang, T. J. (1991). Diagnosis and therapy of herpes zoster oph-thalmicus. Ophthalmology, 98(8), 1216-1229.
41. Mallory, S., Sommer, M., and Arvin, A. M. (1997). Mutational analy-sis of the role of glycoprotein I in varicella-zoster virus replica-tion and its effects on glycoprotein E conformation and traf-cking. J. Virol., 71(11), 8279-8288.
42. Mo, C., Suen, J., Sommer, M., and Arvin, A. (1999). Characteriza-tion of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J. Virol., 73(5), 4197-4207.
43. Mo, C., Lee, J., Sommer, M., Grose, C., and Arvin, A. M. (2002). The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology, 304(2), 176-186.
44. Moffat, J., Ito, H., Sommer, M., Taylor, S., and Arvin, A. M.(2002). Gly-coprotein I of varicella-zoster virus is required for viral repli-cation in skin and T cells. J. Virol., 76(16), 8468-8471.
45. Moffat, J., Mo, C., Cheng, J. J. et al. (2004a). Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. J. Virol., 78(22), 12406-12415.
46. Moffat, J. F., McMichael, M. A., Leisenfelder, S. A., and Taylor, S. L. (2004b). Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis. Biochim. Biophys. Acta., 1697(1-2), 225-231.
47. Moffat, J. F., Stein, M. D., Kaneshima, H., and Arvin, A. M. (1995). Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol., 69(9), 5236-5242.
48. Moffat, J. F., Zerboni, L., Sommer, M. H. et al. (1998). The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl Acad. Sci. USA, 95(20), 11969-11974.
49. Myers, M. G. (1979). Viremia caused by varicella-zoster virus: Asso-ciation with malignant progressive varicella. J. Infect. Dis., 140, 229-233.
50. Niizuma, T., Zerboni, L., Sommer, M. H., Ito, H., Hinchliffe, S., and Arvin, A. M. (2003). Construction of varicella-zoster virus recombinants from parent oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J. Virol., 77(10), 6062-6065.
51. Olashaw, N. and Pledger, W. J. (2002). Paradigms of growth control: Relation to Cdk activation. Sci. STKE, 2002(134), RE7.
52. Ozaki, T., Ichikawa, T., Matsui, Y. et al. (1986). Lymphocyte-associated viremia in varicella. J. Med. Virol., 19, 249-253.
53. Pastuszak, A. L., Levy, M., Schick, B. et al. (1994). Outcome after maternal varicella infection in the rst 20 weeks of pregnancy. N. Engl. J. Med., 330(13), 901-905.
54. Peters, A. C., Versteeg, J., Lindeman, J., and Bots, G. T. (1978). Vari-cella and acute cerebellar ataxia. Arch. Neurol., 35(11), 769-771.
55. Preblud, S. R., Bregman, D. J., and Vernon, L. L. (1985). Deaths from varicella in infants. Pediatr. Infect. Dis., 4(5), 503-507.
56. Sato, B., Ito, H., Hinchliffe, S., Sommer, M. H., Zerboni, L., and Arvin, A. M. (2003a). Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J. Virol., 77(10), 5607-5620.
57. Sato, B., Sommer, M., Ito, H., and Arvin, A. M. (2003b). Require-ment of varicella-zoster virus immediate-early 4 protein for viral replication. J. Virol., 77(22), 12369-12372.
58. Schaap, A., Fortin, J. F., Sommer, M. et al. (2005). T-cell tropism and the role of ORF66 protein in the pathogenesis of varicella-zoster virus infection. J. Virol., 79, 12921-33.
59. Sommer, M. H., Zagha, E., Serrano, O. K. et al. (2001). Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J. Virol., 75(17), 8224-8239.
60. Soong, W., Schultz, J. C., Patera, A. C., Sommer, M. H., and Cohen, J. I. (2000). Infection of human T lymphocytes with varicella-zoster virus: An analysis with viral mutants and clin-ical isolates. J. Virol., 74(4), 1864-1870.
61. Takahashi, K., Sonoda, S., Higashi, K. et al.(1989). Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol., 63(7), 3161-3163.
62. Taylor, S. L., Kinchington, P. R., Brooks, A., and Moffat, J. F. (2004). Roscovitine, a cyclin dependent kinase inhibitor, prevents replication of varicella-zoster virus. J. Virol., 78(6), 2853-2862.
63. Ye, M., Duus, K. M., Peng, J., Price, D. H., and Grose, C. (1999). Varicella-zoster virus Fc receptor component gI is phosphory-lated on its endodomain by a cyclin-dependent kinase. J. Virol., 73(2), 1320-1330.